Emara, M. (2022). Inhaled Steroids for Misdiagnosed Asthma Increase the Frequency of Esophageal Moniliasis in Patients with Achalasia. Afro-Egyptian Journal of Infectious and Endemic Diseases, 12(3), 298-299. doi: 10.21608/aeji.2022.259882
Mohamed H Emara. "Inhaled Steroids for Misdiagnosed Asthma Increase the Frequency of Esophageal Moniliasis in Patients with Achalasia". Afro-Egyptian Journal of Infectious and Endemic Diseases, 12, 3, 2022, 298-299. doi: 10.21608/aeji.2022.259882
Emara, M. (2022). 'Inhaled Steroids for Misdiagnosed Asthma Increase the Frequency of Esophageal Moniliasis in Patients with Achalasia', Afro-Egyptian Journal of Infectious and Endemic Diseases, 12(3), pp. 298-299. doi: 10.21608/aeji.2022.259882
Emara, M. Inhaled Steroids for Misdiagnosed Asthma Increase the Frequency of Esophageal Moniliasis in Patients with Achalasia. Afro-Egyptian Journal of Infectious and Endemic Diseases, 2022; 12(3): 298-299. doi: 10.21608/aeji.2022.259882
Inhaled Steroids for Misdiagnosed Asthma Increase the Frequency of Esophageal Moniliasis in Patients with Achalasia
Hepatology, Gastroenterology and Infectious Diseases Department ,Faculty of Medicine , Kafrelshiekh University , KAFR ELSHIEKH ,Egypt
Abstract
A55-yearold patient with dysphagia had years of aspirations and was given inhaled steroids for misdiagnosed asthma and upon endoscopic examination besides manifestations of achalasia found to have sever oesophageal moniliasis.
Candida Albicans (esophageal moniliasis) is the most common cause of infectious esophagitis so far. However, this kind of infectious esophagitis is linked to immunocompromized conditions e.g. uncontrolled diabetes, HIV infection, patients with advanced malignancy, and with prolonged heavy steroids use. Furthermore, infrequently patients with achalasia and other obstructive lesions of the esophagus with prolonged food stasis have been diagnosed with this infection [1,2]. The case presented her is educational from different points. First, the clinical inertia. This patient had years of complaints and per the current practice guidelines [3] he should have been investigated by either imaging studies or endoscopy years back for both the persistent pain and the progressive dysphagia particularly with failure of empirical PPI therapy and persistence of complains. Second, the misdiagnosis of asthma. In patients with achalasia, like our patient, with stagnation of the food residues, recurrent aspirations with cough and sometimes wheezes are occasionally misdiagnosed as asthma. This further complicated the case because the inhaled steroids [4], as those given to our case, are well known risk factors for the local fungal infection and this explains the extensive affection seen in this patient. The extensive candidiasis shown in Figure 1 B should draw attention of clinicians to the odynophagic effect of this infection among this category of patients
Case Presentation
A 55-year old male patient with hypertension on amlodipine had 4-5 years history of central chest discomfort, dysphagia, with cough and was misdiagnosed as GERD and asthma and given multiple courses of proton pump inhibitors (PPIs) and due to cough was diagnosed as asthma and kept on inhaled steroid (budesonide) in combination with a long-acting bronchodilator (formoterol fumarate dihydrate). The patient when evaluated in our clinic 2-months ago did not fulfill the diagnostic criteria of GERD and with the presence of the alaram manifestation dysphagia a decision for upper endoscopy was taken and it revealed markedly dilated esophagus, tight lower esophageal sphincter and diffuse esophageal moniliasis (Figure 1 A) that was confirmed in the films done for the brushes and on histopathology specimens taken to rule out pseudoachalasia. The patient was then examined by barium swallow that showed dilated esophagus with smooth tapering lower end (Figure 1 B). The patient was treated for esophageal moniliasis with oral antifungals for 2 weeks, followed by pneumatic dilation by 30 mm balloon, and the inhaled steroids were discontinued.
DECLARATION
i. Funding: None
ii. Conflicts of interest/Competing interests: None
iii. Ethics approval: Approved.
iv.Consent to participate: written informed consent taken from the patient
v. Consent for publication: written informed consent taken from the patient
vi. Availability of data and material: Available on request
vii. Code availability: Not applicable
viii. Authors' contributions: ME diagnosed the case, performed endoscopy, wrote the article an approved it
References
1. Kumar P, Mohan S, Verma A, Baijal SS. Candida esophagitis in achalasia cardia: Case report and review of literature. Saudi J Gastroenterol 2007; 13:88-90.
2.Wibowo AP, Perdana RF, Herawati S. Case report: Management of achalasia with esophageal candidiasis and bradycardia at tertiary hospital. Eurasia J Biosci 2000; 14: 6931-6937.
3.Hoversten P, Otaki F, Katzka DA. Course of Esophageal Candidiasis and Outcomes of Patients at a Single Center. Clin Gastroenterol Hepatol. 2019 Jan; 17(1):200-202.e1. doi: 10.1016/j.cgh.2018.04.035. Epub 2018 Apr 24. PMID: 29702297.
4. Oude Nijhuis RAB, Zaninotto G, Roman S, Boeckxstaens GE, Fockens P, Langendam MW, Plumb AA, Smout A, Targarona EM, Trukhmanov AS, Weusten B, Bredenoord AJ. European guidelines on achalasia: United European Gastroenterology and European Society of Neurogastroenterology and Motility recommendations. United European Gastroenterol J. 2020 Feb; 8(1):13-33. doi: 10.1177/2050640620903213. PMID: 32213062; PMCID: PMC7005998